News related to Paraplatin (Carboplatin) and/or conditions it is approved for
Relapsed Ovarian Cancer Responds to Pegylated Liposomal Doxorubicin-Carboplatin
Source: Medscape Pharmacotherapy Headlines [2004.06.10]
The treatment reduces alopecia and neurotoxicity.
Medscape Medical News
Peggy Peck
Amgen, Takeda And Millennium Provide Update On Phase 3 Trial Of Motesanib In Patients With Non Small Cell Lung Cancer
Source: Lung Cancer News From Medical News Today [2008.11.21]
Amgen (Nasdaq: AMGN) and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited (TSE: 4052), announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC).
Study First To Combine 2 Chemotherapies And 2 Targeted Therapies
Source: Lung Cancer News From Medical News Today [2008.11.14]
The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a cooperative group study led by The University of Texas M. D. Anderson Cancer Center.
Blogs Examine Obama Appointees, Ovarian Cancer Test, European Abortion Laws
Source: Abortion News From Medical News Today [2008.11.26]
The following is a summary of selected women's health-related blog entries.~ "Progressive and Pro-Choice: Obama's Latest Team Members," Amie Newman, RH Reality Check: Newman reports that two of President-elect Barack Obama's latest appointments to his incoming administration "offer much hope to advocates of women's rights.
ASRM: Ovarian Cancer Risk Increased After In Vitro Fertilization
Source: MedPage Today Endocrinology [2008.11.20]
SAN FRANCISCO (MedPage Today) -- In vitro fertilization is associated with an increased risk of ovarian malignancies, particularly borderline tumors -- but the absolute risk of these uncommon malignancies remains small, a large study showed.
Small Victories in the War Against Ovarian Cancer
Source: MedicineNet Abdominal Pain Specialty [2008.10.20]
Title: Small Victories in the War Against Ovarian Cancer
Category: Health News
Created: 10/20/2008 2:00:00 AM
Last Editorial Review: 10/20/2008
Researchers ID Ovarian Cancer Biomarker
Source: MedicineNet Ovarian Cancer Specialty [2008.09.24]
Title: Researchers ID Ovarian Cancer Biomarker
Category: Health News
Created: 9/24/2008 2:00:00 AM
Last Editorial Review: 9/24/2008
Drug Combo Fights Recurrent Ovarian Cancer Cell Growth
Source: MedicineNet Clinical Trials Specialty [2008.09.19]
Title: Drug Combo Fights Recurrent Ovarian Cancer Cell Growth
Category: Health News
Created: 9/19/2008 2:00:00 AM
Last Editorial Review: 9/19/2008
Ovarian Cancer
Source: MedicineNet Cancer Detection Specialty [2008.07.10]
Title: Ovarian Cancer
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 7/10/2008
Symptoms Warn of Ovarian Cancer
Source: MedicineNet Inflammatory Bowel Disease: Intestinal Problems Specialty [2008.06.24]
Title: Symptoms Warn of Ovarian Cancer
Category: Health News
Created: 6/24/2008
Last Editorial Review: 6/24/2008
Ovarian Cancer Symptoms, Early Warning Signs, and Risk Factors
Source: MedicineNet Ovarian Cysts Specialty [2007.06.14]
Title: Ovarian Cancer Symptoms, Early Warning Signs, and Risk Factors
Category: Doctor's Views
Created: 5/6/2005
Last Editorial Review: 6/14/2007
Thalidomide plus Topotecan better for ovarian cancer
Source: The Doctors Lounge - Oncology
This trial is among the first to combine a biologic agent with a conventional chemotherapy agent for ovarian cancer.
Study Unmasks How Ovarian Tumors Evade Immune System
Source: Cancer / Oncology News From Medical News Today [2008.12.01]
Scientists at Johns Hopkins have determined how the characteristic shedding of fatty substances, or lipids, by ovarian tumors allows the cancer to evade the body's immune system, leaving the disease to spread unchecked. Ovarian cancer is considered to be one of the most aggressive malignancies, killing more than 70 percent of diagnosed women within five years, including an estimated 15,000 this year.
|
